Merck slump could mean 7,200 jobs
TEXT OF STORY
Renita Jablonski: More losses from big names today, raising the worry even further we’re in for a pretty severe recession. Aircraft maker Boeing says its third-quarter earnings dipped by 38 percent. Drug company Merck is swallowing a 28 percent loss. And that’s not all, as Marketplace’s Jennifer Collins reports.
Jennifer Collins: Americans seem to be cutting back on those costly spoonfuls of medicine these days. Brand named drugs are losing ground to generics in this economic downturn.
That’s the message behind this morning’s disappointing earnings at Merck. Sales were down 2 percent. The pharma company now says it’s planning to cut 12 percent of its work force — that’s 7,200 jobs.
The New Jersey-based drugmaker blames falling sales. Earlier this week, Pfizer also reported a slump in sales, but said cost cuts helped keep the company’s profits impressive.
I’m Jennifer Collins for Marketplace.
Stories You Might Like
There’s a lot happening in the world. Through it all, Marketplace is here for you.
You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible.
Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.
